▶ 調査レポート

世界の血管炎薬市場2019
• 英文タイトル：Global Vasculitis Drug Sales Market Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の血管炎薬市場2019 / Global Vasculitis Drug Sales Market Report 2019 / QYR9N5459資料のイメージです。• レポートコード：QYR9N5459
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥592,000 (USD4,000)▷ お問い合わせ
  Enterprise License￥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
本調査レポートでは、血管炎薬の世界市場について調査・分析し、血管炎薬のメーカー別販売量、市場シェア分析、種類別販売分析（ブリシビモド、CCX-168、ゲボキズマブ、リツキシマブバイオシミラー、その他）、用途別販売分析（結節性多発動脈炎、血栓性血管炎、肉芽腫性血管炎、リンパ球性血管炎、その他）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・血管炎薬市場概要
・血管炎薬のメーカー別販売量・メーカー別シェア
・血管炎薬の種類別販売量（ブリシビモド、CCX-168、ゲボキズマブ、リツキシマブバイオシミラー、その他）
・血管炎薬の用途別販売量（結節性多発動脈炎、血栓性血管炎、肉芽腫性血管炎、リンパ球性血管炎、その他）
・血管炎薬の地域別販売量・市場シェア
・血管炎薬の米国市場規模（2014年-2019年）
・血管炎薬のヨーロッパ市場規模（2014年-2019年）
・血管炎薬の中国市場規模（2014年-2019年）
・血管炎薬の日本市場規模（2014年-2019年）
・血管炎薬の東南アジア市場規模（2014年-2019年）
・血管炎薬のインド市場規模（2014年-2019年）
・血管炎薬メーカー分析（企業概要、製品概要、販売量、売上、価格等）
・血管炎薬のコスト分析
・血管炎薬販売チャネル、流通業者、顧客
・血管炎薬の世界市場動向・機会・成長要因・課題
・血管炎薬の種類別世界市場予測（ブリシビモド、CCX-168、ゲボキズマブ、リツキシマブバイオシミラー、その他）
・血管炎薬の用途別世界市場予測（結節性多発動脈炎、血栓性血管炎、肉芽腫性血管炎、リンパ球性血管炎、その他）
・血管炎薬の米国市場予測（2019年-2025年）
・血管炎薬のヨーロッパ市場予測（2019年-2025年）
・血管炎薬の中国市場予測（2019年-2025年）
・血管炎薬の日本市場予測（2019年-2025年）
・血管炎薬の東南アジア市場予測（2019年-2025年）
・血管炎薬のインド市場予測（2019年-2025年）
...

The global Vasculitis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Vasculitis Drug market status and forecast, categorizes the global Vasculitis Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Merck
Bayer
Farmalider
Hainan Pharmaceutical Factory
Shanghaihuangxiang Lantian Pharmaceutical
Huzhou Konch Pharmaceutical
CSPC Ouyi Pharmaceutical
Sino-US Zibo Xinhua-Perrigo Pharmaceutical
Hubei Biocause Pharmaceutical

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Blisibimod
CCX-168
Gevokizumab
Rituximab Biosimilar
Others

Segment by Application
Polyarteritis Nodosa
Thrombotic Vasculitis
Granulomatous Vasculitis
Lymphocytic Vasculitis
Others

レポート目次

Table of Contents

Global Vasculitis Drug Sales Market Report 2019
1 Vasculitis Drug Market Overview
1.1 Vasculitis DrugProduct Overview
1.2 Vasculitis Drug Segment by Type
1.2.1 Global Vasculitis Drug Sales Comparison by Types (2014-2025)
1.2.2 Blisibimod
1.2.3 CCX-168
1.2.4 Gevokizumab
1.2.5 Rituximab Biosimilar
1.2.6 Others
1.3 Vasculitis Drug Segment by Application
1.3.1 Global Vasculitis Drug Sales Comparison by Application (2014-2025)
1.3.1 Polyarteritis Nodosa
1.3.2 Thrombotic Vasculitis
1.3.3 Granulomatous Vasculitis
1.3.4 Lymphocytic Vasculitis
1.3.5 Others
1.4 Vasculitis Drug Market by Region
1.4.1 Global Vasculitis Drug Revenue Comparison by Region (2014-2025)
1.4.2 United States Vasculitis Drug Status and Prospect (2014-2025)
1.4.3 Europe Vasculitis Drug Status and Prospect (2014-2025)
1.4.4 China Vasculitis Drug Status and Prospect (2014-2025)
1.4.5 Japan Vasculitis Drug Status and Prospect (2014-2025)
1.4.6 Southeast Asia Vasculitis Drug Status and Prospect (2014-2025)
1.4.7 India Vasculitis Drug Status and Prospect (2014-2025)
1.5 Global Vasculitis Drug Sales and Revenue (2014-2025)
1.5.1 Global Vasculitis Drug Sales and Growth Rate (2014-2025)
1.5.2 Global Vasculitis Drug Revenue and Growth Rate (2014-2025)

2 Vasculitis Drug by Company, Region, Type and Application
2.1 Global Vasculitis Drug Market Competition by Companies
2.1.1 Global Vasculitis Drug Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Vasculitis Drug Revenue Market Share by Company (2014-2019)
2.2 Global Vasculitis Drug Sales and Revenue by Region
2.2.1 Global Vasculitis Drug Sales Market Share by Region (2014-2019)
2.2.2 Global Vasculitis Drug Revenue Market Share by Region (2014-2019)
2.3 Global Vasculitis Drug Sales and Revenue by Type
2.3.1 Global Vasculitis Drug Sales Market Share by Type (2014-2019)
2.3.2 Global Vasculitis Drug Revenue Market Share by Type (2014-2019)
2.4 Global Vasculitis Drug Sales by Application

3 United States Vasculitis Drug Sales, Revenue and Price
3.1 United States Vasculitis Drug Sales and Revenue (2014-2019)
3.1.1 United States Vasculitis Drug Sales Growth Rate (2014-2019)
3.1.2 United States Vasculitis Drug Revenue Growth Rate (2014-2019)
3.1.3 United States Vasculitis Drug Price Trend (2014-2019)
3.2 United States Vasculitis Drug Sales Market Share by Company
3.3 United States Vasculitis Drug Sales Market Share by Type
3.4 United States Vasculitis Drug Sales Market Share by Application

4 Europe Vasculitis Drug Sales, Revenue and Price
4.1 Europe Vasculitis Drug Sales and Value (2014-2019)
4.1.1 Europe Vasculitis Drug Sales Growth Rate (2014-2019)
4.1.2 Europe Vasculitis Drug Revenue Growth Rate (2014-2019)
4.1.3 Europe Vasculitis Drug Price Trend (2014-2019)
4.2 Europe Vasculitis Drug Sales Market Share by Company
4.3 Europe Vasculitis Drug Sales Market Share by Type
4.4 Europe Vasculitis Drug Sales Market Share by Application

5 China Vasculitis Drug Sales, Revenue and Price
5.1 China Vasculitis Drug Sales and Revenue (2014-2019)
5.1.1 China Vasculitis Drug Sales Growth Rate (2014-2019)
5.1.2 China Vasculitis Drug Revenue Growth Rate (2014-2019)
5.1.3 China Vasculitis Drug Price Trend (2014-2019)
5.2 China Vasculitis Drug Sales Market Share by Company
5.3 China Vasculitis Drug Sales Market Share by Type
5.4 China Vasculitis Drug Sales Market Share by Application

6 Japan Vasculitis Drug Sales, Revenue and Price
6.1 Japan Vasculitis Drug Sales and Value (2014-2019)
6.1.1 Japan Vasculitis Drug Sales Growth Rate (2014-2019)
6.1.2 Japan Vasculitis Drug Revenue Growth Rate (2014-2019)
6.1.3 Japan Vasculitis Drug Price Trend (2014-2019)
6.2 Japan Vasculitis Drug Sales Market Share by Company
6.3 Japan Vasculitis Drug Sales Market Share by Type
6.4 Japan Vasculitis Drug Sales Market Share by Application

7 Southeast Asia Vasculitis Drug Sales, Revenue and Price
7.1 Southeast Asia Vasculitis Drug Sales and Value (2014-2019)
7.1.1 Southeast Asia Vasculitis Drug Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Vasculitis Drug Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Vasculitis Drug Price Trend (2014-2019)
7.2 Southeast Asia Vasculitis Drug Sales Market Share by Company
7.3 Southeast Asia Vasculitis Drug Sales Market Share by Type
7.4 Southeast Asia Vasculitis Drug Sales Market Share by Application

8 India Vasculitis Drug Sales, Revenue and Price
8.1 India Vasculitis Drug Sales and Value (2014-2019)
8.1.1 India Vasculitis Drug Sales Growth Rate (2014-2019)
8.1.2 India Vasculitis Drug Revenue Growth Rate (2014-2019)
8.1.3 India Vasculitis Drug Price Trend (2014-2019)
8.2 India Vasculitis Drug Sales Market Share by Company
8.3 India Vasculitis Drug Sales Market Share by Type
8.4 India Vasculitis Drug Sales Market Share by Application

9 Company Profiles and Key Figures in Vasculitis Drug Business
9.1 Merck
9.1.1 Merck Vasculitis Drug Production Sites and Area Served
9.1.2 Vasculitis Drug Specification and Application
9.1.3 Merck Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Bayer
9.2.1 Bayer Vasculitis Drug Production Sites and Area Served
9.2.2 Vasculitis Drug Specification and Application
9.2.3 Bayer Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Farmalider
9.3.1 Farmalider Vasculitis Drug Production Sites and Area Served
9.3.2 Vasculitis Drug Specification and Application
9.3.3 Farmalider Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Hainan Pharmaceutical Factory
9.4.1 Hainan Pharmaceutical Factory Vasculitis Drug Production Sites and Area Served
9.4.2 Vasculitis Drug Specification and Application
9.4.3 Hainan Pharmaceutical Factory Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Shanghaihuangxiang Lantian Pharmaceutical
9.5.1 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Production Sites and Area Served
9.5.2 Vasculitis Drug Specification and Application
9.5.3 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Huzhou Konch Pharmaceutical
9.6.1 Huzhou Konch Pharmaceutical Vasculitis Drug Production Sites and Area Served
9.6.2 Vasculitis Drug Specification and Application
9.6.3 Huzhou Konch Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 CSPC Ouyi Pharmaceutical
9.7.1 CSPC Ouyi Pharmaceutical Production Sites and Area Served
9.7.2 Vasculitis Drug Specification and Application
9.7.3 CSPC Ouyi Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served
9.8 Sino-US Zibo Xinhua-Perrigo Pharmaceutical
9.8.1 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Production Sites and Area Served
9.8.2 Vasculitis Drug Specification and Application
9.8.3 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.8.4 Main Business and Markets Served
9.9 Hubei Biocause Pharmaceutical
9.9.1 Hubei Biocause Pharmaceutical Vasculitis Drug Production Sites and Area Served
9.9.2 Vasculitis Drug Specification and Application
9.9.3 Hubei Biocause Pharmaceutical Vasculitis Drug Sales, Revenue, Price and Gross Margin (2014-2019)
9.9.4 Main Business and Markets Served

10 Vasculitis Drug Maufacturing Cost Analysis
10.1 Vasculitis Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Vasculitis Drug
10.4 Vasculitis Drug Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Vasculitis Drug Distributors List
11.3 Vasculitis Drug Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Vasculitis Drug Market Forecast
13.1 Global Vasculitis Drug Sales, Revenue and Price Forecast
13.1.1 Global Vasculitis Drug Sales Growth Forecast (2019-2025)
13.1.2 Global Vasculitis Drug Revenue Growth Forecast (2019-2025)
13.1.3 Global Vasculitis Drug Price Trend Forecast (2019-2025)
13.2 Global Vasculitis Drug Forecast by Region
13.2.1 Global Vasculitis Drug Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Vasculitis Drug Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Vasculitis Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Vasculitis Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Vasculitis Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Vasculitis Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Vasculitis Drug Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Vasculitis Drug Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Vasculitis Drug Forecast by Type
13.3.1 Global Vasculitis Drug Sales Forecast by Type (2019-2025)
13.3.2 Global Vasculitis Drug Revenue Forecast by Type (2019-2025)
13.3.3 Global Vasculitis Drug Price Forecast by Type (2019-2025)
13.4 Global Vasculitis Drug Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

List of Tables and Figures

Market Breakdown by Region: Vasculitis Drug Sales (K Pcs) and Value (Revenue: Million US$)
Market Breakdown by Type: Vasculitis Drug Sales (K Pcs) and Revenue (Million US$)
Market Breakdown by Application: Vasculitis Drug Sales (Jan)
Figure Vasculitis Drug Product Picture
Table Global Vasculitis Drug Sales (K Pcs) Growth Rate by Types (2014-2025)
Figure Global Vasculitis Drug Sales Market Share by Types in 2018
Figure Blisibimod Product Picture
Figure CCX-168 Product Picture
Figure Gevokizumab Product Picture
Figure Rituximab Biosimilar Product Picture
Figure Others Product Picture
Table Global Vasculitis Drug Sales (K Pcs) Comparison by Application (2014-2025)
Figure Global Sales Market Share of Vasculitis Drug by Application in 2018
Figure Polyarteritis Nodosa Examples
Figure Thrombotic Vasculitis Examples
Figure Granulomatous Vasculitis Examples
Figure Lymphocytic Vasculitis Examples
Figure Others Examples
Table Global Market Vasculitis Drug Revenue (Million USD) Comparison by Region 2014-2025
Figure United States Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Southeast Asia Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure India Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Vasculitis Drug Sales (K Pcs) Growth Rate (2014-2025)
Figure Global Vasculitis Drug Revenue (Million USD) Growth Rate (2014-2025)
Table Global Vasculitis Drug Sales (K Pcs) of Key Companies (2014-2019)
Figure Global Vasculitis Drug Sales by Company in 2018
Table Global Vasculitis Drug Sales Share by Company (2014-2019)
Figure Global Vasculitis Drug Sales Share by Company in 2018
Table Global Vasculitis Drug Revenue (Million USD) by Company (2014-2019)
Figure Global Vasculitis Drug Revenue (Million USD) by Company in 2018
Table Global Vasculitis Drug Revenue Share by Company (2014-2019)
Figure Global Vasculitis Drug Revenue Share by Company in 2018
Table Global Vasculitis Drug Sales (K Pcs) Market Share by Region (2014-2019)
Table Global Vasculitis Drug Sales Share by Region (2014-2019)
Figure Global Vasculitis Drug Sales Share by Region in 2018
Table Global Vasculitis Drug Revenue (Million USD) Market Share by Region (2014-2019)
Table Global Vasculitis Drug Revenue Share by Region (2014-2019)
Figure Global Vasculitis Drug Revenue Market Share by Region In 2018
Table Global Vasculitis Drug Sales (K Pcs) by Type (2014-2019)
Table Global Vasculitis Drug Sales Share by Type (2014-2019)
Figure Global Vasculitis Drug Sales Growth Rate by Type in 2018
Table Global Vasculitis Drug Revenue (Million USD) Market Share by Type (2014-2019)
Table Global Vasculitis Drug Revenue Share by Type (2014-2019)
Figure Global Vasculitis Drug Revenue Growth Rate by Type in 2018
Table Global Vasculitis Drug Sales Market Share by Application (2014-2019)
Table Global Vasculitis Drug Sales Share by Application (2014-2019)
Figure Global Vasculitis Drug Sales Market Share by Application in 2018
Figure United States Vasculitis Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure United States Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure United States Vasculitis Drug Price (USD/Pcs) Trend (2014-2019)
Table United States Vasculitis Drug Sales (K Pcs) by Company (2014-2019)
Table United States Vasculitis Drug Sales Market Share by Company (2014-2019)
Figure United States Vasculitis Drug Sales Market Share by Company in 2018
Table United States Vasculitis Drug Sales (K Pcs) by Type (2014-2019)
Table United States Vasculitis Drug Sales Market Share by Type (2014-2019)
Figure United States Vasculitis Drug Sales Market Share by Type in 2018
Table United States Vasculitis Drug Sales (K Pcs) by Application (2014-2019)
Table United States Vasculitis Drug Sales Market Share by Application (2014-2019)
Figure United States Vasculitis Drug Sales Market Share by Application in 2018
Figure Europe Vasculitis Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure Europe Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Europe Vasculitis Drug Price (USD/Pcs) Trend (2014-2019)
Table Europe Vasculitis Drug Sales (K Pcs) by Company (2014-2019)
Table Europe Vasculitis Drug Sales Market Share by Company (2014-2019)
Figure Europe Vasculitis Drug Sales Market Share by Company in 2018
Table Europe Vasculitis Drug Sales (K Pcs) by Type (2014-2019)
Table Europe Vasculitis Drug Sales Market Share by Type (2014-2019)
Figure Europe Vasculitis Drug Sales Market Share by Type in 2018
Table Europe Vasculitis Drug Sales (K Pcs) by Application (2014-2019)
Table Europe Vasculitis Drug Sales Market Share by Application (2014-2019)
Figure Europe Vasculitis Drug Sales Market Share by Application in 2018
Figure China Vasculitis Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure China Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure China Vasculitis Drug Price (USD/Pcs) Trend (2014-2019)
Table China Vasculitis Drug Sales (K Pcs) by Company (2014-2019)
Table China Vasculitis Drug Sales Market Share by Company (2014-2019)
Figure China Vasculitis Drug Sales Market Share by Company in 2018
Table China Vasculitis Drug Sales (K Pcs) by Type (2014-2019)
Table China Vasculitis Drug Sales Market Share by Type (2014-2019)
Figure China Vasculitis Drug Sales Market Share by Type in 2018
Table China Vasculitis Drug Sales (K Pcs) by Application (2014-2019)
Table China Vasculitis Drug Sales Market Share by Application (2014-2019)
Figure China Vasculitis Drug Sales Market Share by Application in 2018
Figure Japan Vasculitis Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure Japan Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Japan Vasculitis Drug Price (USD/Pcs) Trend (2014-2019)
Table Japan Vasculitis Drug Sales (K Pcs) by Company (2014-2019)
Table Japan Vasculitis Drug Sales Market Share by Company (2014-2019)
Figure Japan Vasculitis Drug Sales Market Share by Company in 2018
Table Japan Vasculitis Drug Sales (K Pcs) by Type (2014-2019)
Table Japan Vasculitis Drug Sales Market Share by Type (2014-2019)
Figure Japan Vasculitis Drug Sales Market Share by Type in 2018
Table Japan Vasculitis Drug Sales (K Pcs) by Application (2014-2019)
Table Japan Vasculitis Drug Sales Market Share by Application (2014-2019)
Figure Japan Vasculitis Drug Sales Market Share by Application in 2018
Figure Southeast Asia Vasculitis Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure Southeast Asia Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure Southeast Asia Vasculitis Drug Price (USD/Pcs) Trend (2014-2019)
Table Southeast Asia Vasculitis Drug Sales (K Pcs) by Company (2014-2019)
Table Southeast Asia Vasculitis Drug Sales Market Share by Company (2014-2019)
Figure Southeast Asia Vasculitis Drug Sales Market Share by Company in 2018
Table Southeast Asia Vasculitis Drug Sales (K Pcs) by Type (2014-2019)
Table Southeast Asia Vasculitis Drug Sales Market Share by Type (2014-2019)
Figure Southeast Asia Vasculitis Drug Sales Market Share by Type in 2018
Table Southeast Asia Vasculitis Drug Sales (K Pcs) by Application (2014-2019)
Table Southeast Asia Vasculitis Drug Sales Market Share by Application (2014-2019)
Figure Southeast Asia Vasculitis Drug Sales Market Share by Application in 2018
Figure India Vasculitis Drug Sales (K Pcs) and Growth Rate (2014-2019)
Figure India Vasculitis Drug Revenue (Million USD) and Growth Rate (2014-2019)
Figure India Vasculitis Drug Price (USD/Pcs) Trend (2014-2019)
Table India Vasculitis Drug Sales (K Pcs) by Company (2014-2019)
Table India Vasculitis Drug Sales Market Share by Company (2014-2019)
Figure India Vasculitis Drug Sales Market Share by Company in 2018
Table India Vasculitis Drug Sales (K Pcs) by Type (2014-2019)
Table India Vasculitis Drug Sales Market Share by Type (2014-2019)
Figure India Vasculitis Drug Sales Market Share by Type in 2018
Table India Vasculitis Drug Sales (K Pcs) by Application (2014-2019)
Table India Vasculitis Drug Sales Market Share by Application (2014-2019)
Figure India Vasculitis Drug Sales Market Share by Application in 2018
Table Merck Vasculitis Drug Production Sites and Area Served
Table Merck Vasculitis Drug Specification and Application
Table Merck Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Merck Vasculitis Drug Sales Growth Rate (2014-2019)
Figure Merck Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure Merck Vasculitis Drug Main Business and Markets Served
Table Bayer Vasculitis Drug Production Sites and Area Served
Table Bayer Vasculitis Drug Specification and Application
Table Bayer Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Bayer Vasculitis Drug Sales Growth Rate (2014-2019)
Figure Bayer Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure Bayer Vasculitis Drug Main Business and Markets Served
Table Farmalider Vasculitis Drug Production Sites and Area Served
Table Farmalider Vasculitis Drug Specification and Application
Table Farmalider Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Farmalider Vasculitis Drug Sales Growth Rate (2014-2019)
Figure Farmalider Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure Farmalider Vasculitis Drug Main Business and Markets Served
Table Hainan Pharmaceutical Factory Vasculitis Drug Production Sites and Area Served
Table Hainan Pharmaceutical Factory Vasculitis Drug Specification and Application
Table Hainan Pharmaceutical Factory Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Sales Growth Rate (2014-2019)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure Hainan Pharmaceutical Factory Vasculitis Drug Main Business and Markets Served
Table Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Production Sites and Area Served
Table Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Specification and Application
Table Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales Growth Rate (2014-2019)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Main Business and Markets Served
Table Huzhou Konch Pharmaceutical Vasculitis Drug Production Sites and Area Served
Table Huzhou Konch Pharmaceutical Vasculitis Drug Specification and Application
Table Huzhou Konch Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Sales Growth Rate (2014-2019)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure Huzhou Konch Pharmaceutical Vasculitis Drug Main Business and Markets Served
Table CSPC Ouyi Pharmaceutical Vasculitis Drug Production Sites and Area Served
Table CSPC Ouyi Pharmaceutical Vasculitis Drug Specification and Application
Table CSPC Ouyi Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Sales Growth Rate (2014-2019)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure CSPC Ouyi Pharmaceutical Vasculitis Drug Main Business and Markets Served
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Production Sites and Area Served
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Specification and Application
Table Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales Growth Rate (2014-2019)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Main Business and Markets Served
Table Hubei Biocause Pharmaceutical Vasculitis Drug Production Sites and Area Served
Table Hubei Biocause Pharmaceutical Vasculitis Drug Specification and Application
Table Hubei Biocause Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Sales Growth Rate (2014-2019)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Revenue Share in International Market (2014-2019)
Figure Hubei Biocause Pharmaceutical Vasculitis Drug Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Key Raw Materials Price Trend
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vasculitis Drug
Figure Manufacturing Process Analysis of Vasculitis Drug
Figure Vasculitis Drug Industrial Chain Analysis
Table Vasculitis Drug Distributors List
Table Vasculitis Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Vasculitis Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Vasculitis Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Vasculitis Drug Price (USD/Pcs) and Trend Forecast (2019-2025)
Table Global Vasculitis Drug Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global Vasculitis Drug Sales Market Share Forecast by Regions (2019-2025)
Figure Global Vasculitis Drug Sales Market Share Forecast by Regions in 2025
Table Global Vasculitis Drug Revenue (Million USD) Forecast by Regions (2019-2025)
Figure Global Vasculitis Drug Revenue Market Share Forecast by Regions (2019-2025)
Figure Global Vasculitis Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Vasculitis Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure United States Vasculitis Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Vasculitis Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Vasculitis Drug Revenue and Growth Rate Forecast (2019-2025)
Figure China Vasculitis Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Vasculitis Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Vasculitis Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Vasculitis Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Vasculitis Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Southeast Asia Vasculitis Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure India Vasculitis Drug Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India Vasculitis Drug Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Vasculitis Drug Sales (K Pcs) Forecast by Type (2019-2025)
Figure Global Vasculitis Drug Sales Market Share Forecast by Type (2019-2025)
Table Global Vasculitis Drug Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Vasculitis Drug Revenue Market Share Forecast by Type (2019-2025)
Table Global Vasculitis Drug Price (USD/Pcs) Forecast by Type (2019-2025)
Table Global Vasculitis Drug Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global Vasculitis Drug Sales Market Share Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界のデシタビン薬市場：市場規模・現状・予測
    Global Decitabine Drug Market Size, Status and Forecast 2019-2025
    QYR9N7070 2019年6月14日 95Pages
    当資料は、デシタビン薬のグローバル市場について調査・分析したレポートで、種類別（ダコゲン、ジェネリック）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・デ...
  • 世界のレボセチリジン薬市場：市場規模・現状・予測
    Global Levocetirizine Drug Market Size, Status and Forecast 2019-2025
    QYR9N7449 2019年6月14日 97Pages
    当資料は、レボセチリジン薬のグローバル市場について調査・分析したレポートで、種類別（錠剤、経口液）、用途別（65歳以上、12〜64歳、6〜11歳、2〜5歳）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界のチゲサイクリン薬市場：市場規模・現状・予測
    Global Tigecycline Drug Market Size, Status and Forecast 2019-2025
    QYR9N8124 2019年6月14日 93Pages
    当資料は、チゲサイクリン薬のグローバル市場について調査・分析したレポートで、種類別（TYGACIL、ジェネリック）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

  • 世界の鎮痛剤デリバリー市場：市場規模・現状・予測
    Global Pain Drug Delivery Market Size, Status and Forecast 2019-2025
    QYR9N7754 2019年6月14日 94Pages
    当資料は、鎮痛剤デリバリーのグローバル市場について調査・分析したレポートで、種類別（経皮ドラッグデリバリーシステム、髄腔内ドラッグデリバリーシステム、その他）、用途別（腫瘍学、神経学的障害、肺疾患、ホルモン障害、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...
  • 世界の過活動膀胱薬市場：市場規模・現状・予測
    Global Overactive Bladder Drug Market Size, Status and Forecast 2019-2025
    QYR9N7749 2019年6月14日 91Pages
    当資料は、過活動膀胱薬のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・過活動膀胱薬の世界市場規模
    ・主...
  • 世界の注射用ドラッグデリバリー市場：市場規模・現状・予測
    Global Injectable Drug Delivery Market Size, Status and Forecast 2019-2025
    QYR9N7368 2019年6月14日 96Pages
    当資料は、注射用ドラッグデリバリーのグローバル市場について調査・分析したレポートで、種類別（皮膚注射、循環/筋骨格注射、臓器注射、中枢神経系注射）、用途別（病院と診療所、在宅ケアの設定、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...
  • 世界の薬物中毒治療市場：市場規模・現状・予測
    Global Drug Addiction Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7131 2019年6月14日 98Pages
    当資料は、薬物中毒治療のグローバル市場について調査・分析したレポートで、種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）、用途別（病院と診療所、住居（病院以外））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...
  • 世界の薬物乱用治療市場：市場規模・現状・予測
    Global Drug Abuse Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7130 2019年6月14日 94Pages
    当資料は、薬物乱用治療のグローバル市場について調査・分析したレポートで、種類別（オピオイド中毒、タバコ/ニコチン中毒、アルコール依存）、用途別（病院と診療所、住居（病院以外））、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...
  • 世界の視神経炎薬市場2019
    Global Optic Neuritis Drug Sales Market Report 2019
    QYR9N3065 2019年6月13日 101Pages
    本調査レポートでは、視神経炎薬の世界市場について調査・分析し、視神経炎薬のメーカー別販売量、市場シェア分析、種類別販売分析（経口コルチコステロイド、静脈内コルチコステロイド、その他）、用途別販売分析（成人、子供）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド）、価格動向、企業動向...
  • 世界のリポソーム薬物送達市場2019
    Global Liposome Drug Delivery Sales Market Report 2019
    QYR9N2277 2019年6月10日 113Pages
    本調査レポートでは、リポソーム薬物送達の世界市場について調査・分析し、リポソーム薬物送達のメーカー別販売量、市場シェア分析、種類別販売分析（リポソームドキソルビシン、リポソームアムホテリシンB、リポソームパクリタキセル、その他）、用途別販売分析（がんと腫瘍治療、真菌感染症治療、その他）、地域別販売分...
  • 世界のスニチニブ薬市場：市場規模・現状・予測世界のスニチニブ薬市場：市場規模・現状・予測 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
  • 世界のデュピュイトラン拘縮薬市場2019世界のデュピュイトラン拘縮薬市場2019 The global Dupuytren Contracture Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Dupuytren Contracture Drug market status and forecast, categorizes the global Dupuytren Contracture Drug…
  • 世界の鼻ポリープ症薬市場2019世界の鼻ポリープ症薬市場2019 The global Nasal Polyposis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Nasal Polyposis Drug market status and forecast, categorizes the global Nasal Polyposis Drug market size (valu…
  • 世界のNSAID薬市場2019世界のNSAID薬市場2019 The global NSAIDs Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global NSAIDs Drug market status and forecast, categorizes the global NSAIDs Drug market size (value & volume) by key players,…
  • 世界のレノックス – ガースト症候群薬市場2019世界のレノックス – ガースト症候群薬市場2019 The global Lennox-Gastaut Syndrome Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Lennox-Gastaut Syndrome Drug market status and forecast, categorizes the global Lennox-Gastaut Syndrom…